Trial Outcomes & Findings for Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis (NCT NCT01525745)

NCT ID: NCT01525745

Last Updated: 2017-03-06

Results Overview

Determine if image-guided radiosurgery/SBRT improves pain control as measured by NPRS as compared to conventional external beam radiotherapy

Recruitment status

TERMINATED

Study phase

PHASE2

Target enrollment

6 participants

Primary outcome timeframe

2 years

Results posted on

2017-03-06

Participant Flow

all participants were enrolled in the RadOnc clinic at BIDMC

Participant milestones

Participant milestones
Measure
Radiosurgery/SBRT
Radiosurgery/SBRT Radiosurgery/SBRT: 1, 3 or 5 SBRT treatments
External Beam Radiation Therapy
External Beam Radiation Therapy External Beam Radiation Therapy: 10 consecutive days of standard radiation
Overall Study
STARTED
4
2
Overall Study
COMPLETED
3
1
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
A/Radiosurgery-SBRT
n=4 Participants
Radiosurgery/SBRT: 1, 3 or 5 SBRT treatments
B/External Beam Radiation Therapy
n=2 Participants
External Beam Radiation Therapy: 10 consecutive days of standard radiation
Total
n=6 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Age, Categorical
>=65 years
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Region of Enrollment
United States
4 participants
n=5 Participants
2 participants
n=7 Participants
6 participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 years

Population: study was terminated by the local IRB due to slow accrual. 1 participant withdrew consent and 1 participant did not complete the assigned arm treatment per protocol and then removed from study. left with 4 participants and data were not collected for any participants therefore no analysis has been done.

Determine if image-guided radiosurgery/SBRT improves pain control as measured by NPRS as compared to conventional external beam radiotherapy

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 2 years

Population: data not collected, therefore no analysis done

Determine if image-guided radiosurgery/SBRT improves duration of pain as compared to conventional external beam radiotherapy

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 2 years

Population: data not collected, therefore no analysis done

Evaluate potential benefit of image-guided radiosurgery/SBRT on change in and overall quality of life as measured by FACT-G, BPI and EQ-5D

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 2 years

Population: data not collected, therefore no analysis done

Long term effects of image-guided radiosurgery/SBRT on the vertevral bone and spinal cord

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 2 years

Population: data not collected, therefore no analysis done

Progrsesion Free and Overall Survival

Outcome measures

Outcome data not reported

Adverse Events

A/Radiosurgery-SBRT

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

B/External Beam Radiation Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Anand Mahadevan, MD

Beth Israel Deaconess Medical Center

Phone: 617-667-2345

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place